Pathophysiology of pulmonary hypertension due to lung disease.

  title={Pathophysiology of pulmonary hypertension due to lung disease.},
  author={Kenneth W. Presberg and H Erhan Dincer},
  journal={Current opinion in pulmonary medicine},
  volume={9 2},
Pulmonary hypertension (PH) often complicates the course of patients with advanced lung disease, and it is associated with a worse prognosis. Per the recent classification of pulmonary hypertensive disorders, PH due to lung disease is considered as a separate category within a group of disorders that was previously referred to as "secondary" PH. Among the lung diseases associated with PH, the incidence and clinical course of PH is best known for patients with COPD. Per studies in patients with… CONTINUE READING
14 Citations
82 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 14 extracted citations


Publications referenced by this paper.
Showing 1-10 of 82 references

Effects of the dual endothelin– receptor antagonist bosentan in patients with pulmonary hypertension : a randomized placebo - controlled study

  • RN Channick, G Simoneau, O Sitbon
  • Lancet
  • 2001

Similar Papers

Loading similar papers…